7 health IT findings from the 2017 Healthcare Prognosis survey

President Donald Trump has had a bit of a turbulent relationship with the healthcare industry, with plans to repeal and replace the Affordable Care Act seemingly in limbo after House Republicans pulled a potential bill before it faced a vote. The Venrock 2017 Healthcare Prognosis survey evaluated how healthcare delivery, policy and information technology companies view the landscape with the new administration.

The survey featured 274 participants from start-ups, large employers and insurance companies to gauge how the industry views the potential for change under the Trump administration.

Top findings included:

  • 12 percent of respondents expect telemedicine to be the least challenged under the new administration, while 10 percent chose wearables.
  • Respondents expect a 60 percent increase in the number of healthcare companies within two years.
  • 72 percent think the Affordable Care Act should be repaired or renamed, 8 percent are in favor of straight repeal and 20 percent hope for repeal and replace.
  • 87 percent believe consolidation of healthcare IT start-ups will increase in the next two years.
  • 85 percent anticipate additional challenges in receiving financing for private healthcare IT companies.
  • 66 percent believe accountable care organizations will be the most challenged health IT subsection under the new administration.
  • 46 percent believe economic uncertainty is the main concern facing healthcare IT innovation within the year.
""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup